Critical Care & Emergencies (all articles)
Clinical update on COVID-19 for the emergency and critical care clinician: Medical management.
11 Apr, 2022 | 02:00h | UTC
Review: Atrial fibrillation.
11 Apr, 2022 | 01:57h | UTCAtrial fibrillation – Nature Reviews Disease Primers (if the link is paywalled, try this one)
Infographic: Atrial fibrillation – Nature Reviews Disease Primers (if the link is paywalled, try this one)
Commentary on Twitter
Get Primed on Atrial fibrillation with our NEW PrimeView! FREE to download this week! #AtrialFibrillation #AFibhttps://t.co/sI8Gx3yHmk pic.twitter.com/r6heFStAz5
— Nature Reviews Disease Primers (@DiseasePrimers) April 7, 2022
RCT: Effect of Gram Stain–Guided initial antibiotic therapy on clinical response in patients with ventilator-associated pneumonia.
11 Apr, 2022 | 01:36h | UTCCommentary: Can Gram Stains Guide Antibiotics for Pneumonia in Critical Care? – Medscape (free registration required)
Commentary on Twitter
RCT found gram stain-guided antibiotic therapy for critically ill patients with VAP was noninferior to guideline-based antibiotics, with a reduction in antipseudomonal & antiMRSA use. https://t.co/1yoHO2pnER
— JAMA Network Open (@JAMANetworkOpen) April 8, 2022
Clinical care of severe acute respiratory infections – Tool kit (COVID-19 adaptation, update 2022).
11 Apr, 2022 | 01:45h | UTCClinical care of severe acute respiratory infections – Tool kit – World Health Organization
Commentary on Twitter (thread – click for more)
Updated toolkit for the clinical care of severe acute respiratory infections including:
🔸 severe #pneumonia
🔸 acute respiratory distress syndrome
🔸 sepsis & septic shock👉 https://t.co/ROvKZz12LT pic.twitter.com/LdcNJiJcxA
— World Health Organization (WHO) (@WHO) April 8, 2022
NCCN Guidelines: CAR T-cell–related toxicities in patients with cancer.
11 Apr, 2022 | 01:32h | UTCRelated:
Reviews: CAR T-Cell Therapy Toxicities and Side Effects
Reviews: CAR T-Cell Therapy Toxicities and Side Effects
Critical Care Management of Chimeric Antigen Receptor T Cell–related Toxicity. Be Aware and Prepared
Reviews: CAR T-Cell Therapy Toxicities and Side Effects
M-A: Oxygen targets during mechanical ventilation in the ICU.
11 Apr, 2022 | 01:26h | UTC
M-A: Prophylactic therapies for morbidity and mortality after aneurysmal subarachnoid hemorrhage.
11 Apr, 2022 | 00:52h | UTCProphylactic Therapies for Morbidity and Mortality After Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Network Meta-Analysis of Randomized Trials – Stroke (link to abstract – $ for full-text)
Commentary on Twitter
Prophylactic Therapies for Morbidity and Mortality After Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Network Meta-Analysis of Randomized Trials #stroke #AHAJournals https://t.co/GkM5GlFBd7 pic.twitter.com/6ipIaUK5KX
— Stroke AHA/ASA (@StrokeAHA_ASA) April 8, 2022
M-A: Prehospital risk assessment in patients suspected of non-ST-segment elevation acute coronary syndrome.
11 Apr, 2022 | 00:48h | UTC
Commentary on Twitter
Prehospital risk assessment in patients suspected of non-ST-segment elevation acute coronary syndrome: a systematic review and meta-analysis https://t.co/tsLld9BEJg #ACS #cardiovascular pic.twitter.com/rUCtXId6Cp
— BMJ_Open (@BMJ_Open) April 6, 2022
RCT: In critically ill children requiring noninvasive respiratory support following extubation, high-flow nasal cannula therapy was NOT noninferior to CPAP, resulting in increased time to liberation from respiratory support.
8 Apr, 2022 | 11:07h | UTCEffect of High-Flow Nasal Cannula Therapy vs Continuous Positive Airway Pressure Following Extubation on Liberation From Respiratory Support in Critically Ill Children: A Randomized Clinical Trial – JAMA (free for a limited period)
Editorial: Selecting Intermediate Respiratory Support Following Extubation in the Pediatric Intensive Care Unit – JAMA (free for a limited period)
News Release: Trial identifies most effective breathing support for children in intensive care – Imperial College London
Commentary on Twitter
In this study, among critically ill children requiring noninvasive respiratory support following extubation, HFNC vs CPAP failed to meet the criterion for noninferiority for time to liberation from respiratory support. https://t.co/X1lNAO28le #CCR pic.twitter.com/XBnUpsqUNq
— JAMA (@JAMA_current) April 7, 2022
State of the Art Review: Prognostication and shared decision making in neurocritical care.
8 Apr, 2022 | 10:53h | UTCPrognostication and shared decision making in neurocritical care – The BMJ
Commentary on Twitter
It's out TODAY: Thank you @bmj_latest for this opportunity as an invited 'State of the Art Review'💥 on such an important topic‼️ Great job @K_Goostrey 👏👏. Proud of this product: 👉Prognostication and Shared Decision Making in #NCC https://t.co/VeFUlRe0xG @UMassChanNeuro
— S Muehlschlegel MD MPH, FNCS, FCCM, FAAN (@SMuehlschMD) April 7, 2022
M-A: Thrombosis patterns and clinical outcome of COVID-19 vaccine-induced immune thrombotic thrombocytopenia.
8 Apr, 2022 | 10:50h | UTCRelated:
Case series of Thrombosis with Thrombocytopenia Syndrome after Covid-19 vaccination in the US.
Review: Vaccine-induced immune thrombotic thrombocytopenia.
Vaccine induced immune thrombocytopenia and thrombosis: summary of NICE guidance.
Clinical features of vaccine-induced immune thrombocytopenia and thrombosis.
Vaccine-induced immune thrombotic thrombocytopenia: what we know and do not know.
Very rare cases of thrombosis with thrombocytopenia syndrome (TTS) after AstraZeneca vaccine: a global safety database analysis – the estimated rate of TTS after the first dose was 8.1 per million vaccinees; after the second dose, the estimated rate was 2.3 per million vaccinees. (several articles and resources on the subject)
M-A: Diagnostic performance of CO-RADS for Covid-19.
8 Apr, 2022 | 10:31h | UTC
Stroke: advances in treatment offer hope for patients.
8 Apr, 2022 | 10:23h | UTCStroke: advances in treatment offer hope for patients – Evidently Cochrane
Study Commentary | Immediate versus delayed cardiac catheterization in post-arrest patients without ST elevation myocardial infarction: is survivorship bias an important influence?
8 Apr, 2022 | 10:11h | UTC
Study Commentary | Back to BaSICS (study that compared balanced solution vs. 0.9% saline solution in critically ill patients).
8 Apr, 2022 | 10:09h | UTCBack to BaSICS – Annals of Emergency Medicine
Original Studies:
Related:
Perspective: The ongoing saga of normal saline vs. balanced fluids.
Study Commentary | To Bougie or not to Bougie: Bougie vs. Stylet for first-pass intubation success.
8 Apr, 2022 | 10:07h | UTC
Brief Review: How to do lung ultrasound.
8 Apr, 2022 | 09:52h | UTCHow to do lung ultrasound – European Heart Journal – Cardiovascular Imaging
Study finds increased risk of pulmonary embolism up to 110 days after COVID-19.
7 Apr, 2022 | 10:06h | UTCNews Release: Study finds increased risk of serious blood clots up to six months after COVID-19 – BMJ
Editorial: Thromboembolism and bleeding after covid-19
Commentary: Covid: Blood clot risk higher for six months after having virus – BBC
Pragmatic RCT: In outpatients with Covid-19, the addition of pulse oximetry for monitoring did not improve outcomes compared to subjective assessments of dyspnea alone.
7 Apr, 2022 | 09:58h | UTC
Commentary on Twitter
A potential practice changer by @kit_delgadoMD et al in NEJM today.
At-home pulse oximeters did NOT improve outcomes.
Important to focus on things that help.
If these devices don't help, then we shouldn't routinely advise them.
Super interesting work.https://t.co/VDDyRLw7ba
— Jeremy Faust MD MS (ER physician) (@jeremyfaust) April 6, 2022
RCT: Among patients with complicated urinary tract infection, oral Tebipenem Pivoxil Hydrobromide was noninferior to intravenous Ertapenem and showed a similar safety profile.
7 Apr, 2022 | 09:53h | UTCOral Tebipenem Pivoxil Hydrobromide in Complicated Urinary Tract Infection – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary on Twitter
For complicated UTI or acute pyelonephritis, oral tebipenem pivoxil hydrobromide noninferior to IV ertapenem and has a similar safety profile. https://t.co/FRDMQOD0Pn pic.twitter.com/GFQz7SlciX
— NEJM (@NEJM) April 6, 2022
RCT: In patients undergoing intraarterial treatment for stroke, functional outcomes after 3 months were similar with general anesthesia vs. sedation.
7 Apr, 2022 | 08:00h | UTC
Commentary on Twitter
Previous speculations have considered the relationship between anesthetic strategy and patient outcomes. Now, new research suggests general #anesthesia and #sedation produce comparable outcomes after endovascular treatment for stroke. https://t.co/ggLRO8Or3W pic.twitter.com/dLLGA4Vmgk
— Anesthesiology (@_Anesthesiology) March 24, 2022
Major burns: part 2. Anesthesia, intensive care and pain management.
7 Apr, 2022 | 07:59h | UTCMajor burns: part 2. Anaesthesia, intensive care and pain management – BJA Education
See also: Major burns: Part 1. Epidemiology, pathophysiology and initial management.
RCT: Effects of clazosentan on cerebral vasospasm–related morbidity and all-cause mortality after aneurysmal subarachnoid hemorrhage.
6 Apr, 2022 | 10:47h | UTC
Craniocervical artery dissections: a concise review for clinicians.
6 Apr, 2022 | 10:06h | UTCCraniocervical Artery Dissections: A Concise Review for Clinicians – Mayo Clinic Proceedings
RCT: Erythropoietin not beneficial for patients with acute kidney injury.
6 Apr, 2022 | 10:02h | UTCErythropoietin in Acute Kidney Injury (EAKI): a pragmatic randomized clinical trial – BMC Nephrology


